Protection from obesity-induced insulin resistance in mice lacking TNF-α function
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitus. The molecular basis of this common syndrome, however, is poorly understood. It has been suggested that tumour necrosis factor (TNF)-alpha is a candidate mediator of insulin resistance in obesity, as it is overexpressed in the adipose tissues of rodents and humans and it blocks the action of insulin in cultured cells and whole animals. To investigate the role of TNF-alpha in obesity and insulin resistance, we have generated obese mice with a targeted null mutation in the gene encoding TNF-alpha and those encoding the two receptors for TNF-alpha. The absence of TNF-alpha resulted in significantly improved insulin sensitivity in both diet-induced obesity and that resulting for the ob/ob model of obesity. The TNFalpha-deficient obese mice had lower levels of circulating free fatty acids, and were protected from the obesity-related reduction in the insulin receptor signalling in muscle and fat tissues. These results indicate that TNF-alpha is an important mediator of insulin resistance in obesity through its effects on several important sites of insulin action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a number of animal studies where inflammatory pathways are genetically down regulated demonstrate that preventing obesity induced inflammation can prevent the development of insulin resistance [159,160].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [159]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“gif" NDATA ITEM> ]> Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitu”
BackgroundWhite, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
The Mouse in Biomedical Research
(1983) · Elsevier eBooks · doi:10.1016/c2013-0-10677-0 · Cited by 1,012
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932 · cited 1×
“To test the importance of the TNFα-activated pathway of insulin resistance in the most severe, genetic model of obesity, we generated genetically obese ( ob/ob ) mice with targeted mutations in both p55 and p75 TNF receptors, effectively abolishing the signalling and function of TNF-α in these animal”
BackgroundHotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Research works printed but not linked: 1
- Olefsky, J. M. & Molina, J. M. in Diabetes Mellitus (eds Rifkin, H. & Porte, D. J.) 121–153 (Elsevier, New York, (1990)).
Cited by
Items 601–700 of 1,010
Kim, K.-Y., Kim, J. K., Jeon, J. H., Yoon, S. R., Choi, I., & Yang, Y. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.026 · Cited by 132
Nutritional factors in the pathobiology of human essential hypertension
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(00)00586-4 · Cited by 129
Interleukins and tumor necrosis factor as inhibitors of food intake
Langhans, W., & Hrupka, B. (1999) · Neuropeptides · doi:10.1054/npep.1999.0048 · Cited by 120
Control of body weight: a physiologic and transgenic perspective
Frühbeck, G., & Gómez‐Ambrosi, J. (2003) · Diabetologia · doi:10.1007/s00125-003-1053-4 · Cited by 126
“TNF-α-deficient mice showed decreased glucose, insulin and leptin concentrations showing an impaired glucose clearance when challenged with a high-fat diet as evidenced by increased circulating glucose and insulin, which did not reach the concentrations of wild-type control mice [10, 96, 152].”
BackgroundEuglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans
Soop, M., Duxbury, H., Agwunobi, A. O., Gibson, J. M., Hopkins, S. J., Childs, C., Cooper, R. G., Maycock, P., Little, R. A., & Carlson, G. L. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00535.2001 · Cited by 118
Hida, K., Wada, J., Zhang, H., Hiragushi, K., Tsuchiyama, Y., Shikata, K., & Makino, H. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31994-5 · Cited by 118
Central Obesity as a Precursor to the Metabolic Syndrome in the AusDiab Study and Mauritius
Cameron, A. J., Boyko, E. J., Sicree, R. A., Zimmet, P. Z., Söderberg, S., Alberti, K. G. M. M., Tuomilehto, J., Chitson, P., & Shaw, J. E. (2008) · Obesity · doi:10.1038/oby.2008.412 · Cited by 116
The roles of c‐Jun NH2‐terminal kinases (JNKs) in obesity and insulin resistance
Pal, M., Febbraio, M. A., & Lancaster, G. I. (2016) · The Journal of Physiology · doi:10.1113/jp271457 · Cited by 114
“…that the expression of the pro-inflammatory cytokine TNFα was elevated in the adipose tissue of obese mice and humans (Hotamisligil et al. 1993, 1995) and that ablation of TNFα’s actions improved insulin sensitivity in rodent models of obesity (Hotamisligil et al. 1993; Uysal et al. 1997).”
BackgroundEnvironmental Contaminants as Risk Factors for Developing Diabetes
Carpenter, D. O. (2008) · Reviews on Environmental Health · doi:10.1515/reveh.2008.23.1.59 · Cited by 127
Prieto, M. A. V., Bettaieb, A., Haj, F. G., Fraga, C. G., & Oteiza, P. I. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.02.019 · Cited by 126
The effect of PPARγ ligands on the adipose tissue in insulin resistance
Hammarstedt, A., Andersson, C. X., Sopasakis, V. R., & Smith, U. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.04.008 · Cited by 135
“Gene ablation of TNF-a or the TNF-a receptor leads to improved insulin sensitivity in rodents [69,70].”
BackgroundTumor necrosis factor-? promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice
BOESTEN, L., ZADELAAR, A., VANNIEUWKOOP, A., GIJBELS, M., DEWINTHER, M., HAVEKES, L., & VANVLIJMEN, B. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.001 · Cited by 116
“demonstrated that the total weight gain in obese Tnf+/+ mice on a high fat diet was larger than that of obese Tnf / mice, which was related to a decrease in fatpad weight [45].”
BackgroundRydén, M., & Arner, P. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01854.x · Cited by 118
Yang, X., Zhang, X., Heckmann, B. L., Lu, X., & Liu, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257923 · Cited by 115
García-Galiano, D., Sanchez-Garrido, M. A., Espejo, I., Montero, J. L., Costán, G., Marchal, T., Membrives, A., Gallardo-Valverde, J. M., Muñoz-Castañeda, J. R., Arévalo, E., et al. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9087-1 · Cited by 125
Strle, K., Broussard, S. R., McCusker, R. H., Shen, W.-H., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2004) · Endocrinology · doi:10.1210/en.2003-1749 · Cited by 115
“7 and 10) and insulin (11, 12) signaling cascades.”
BackgroundEfficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
Omer, Z., Cetinkalp, S., Akyildiz, M., Yilmaz, F., Batur, Y., Yilmaz, C., & Akarca, U. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832e2baf · Cited by 116
Coactivator function of RIP140 for NFκB/RelA-dependent cytokine gene expression
Zschiedrich, I., Hardeland, U., Krones, A., Díaz, M. B., Vegiopoulos, A., Müggenburg, J., Sombroek, D., Hofmann, T. G., Zawatzky, R., Yu, X., et al. (2008) · Blood · doi:10.1182/blood-2007-11-121699 · Cited by 127
Interrelationships Between Inflammation, C‐Reactive Protein, and Insulin Resistance
Ndumele, C. E., Pradhan, A. D., & Ridker, P. M. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05538.x · Cited by 126
Adaptive immunity and adipose tissue biology
Kaminski, D. A., & Randall, T. D. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.08.001 · Cited by 112
miR-155 Deletion in Female Mice Prevents Diet-Induced Obesity
Gaudet, A. D., Fonken, L. K., Gushchina, L. V., Aubrecht, T. G., Maurya, S. K., Periasamy, M., Nelson, R. J., & Popovich, P. G. (2016) · Scientific Reports · doi:10.1038/srep22862 · Cited by 110
Resident and migratory adipose immune cells control systemic metabolism and thermogenesis
Man, K., Kallies, A., & Vasanthakumar, A. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00804-7 · Cited by 128
Diehl, A. M. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.012 · Cited by 126
Imoto, K., Kukidome, D., Nishikawa, T., Matsuhisa, T., Sonoda, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Tsuruzoe, K., et al. (2006) · Diabetes · doi:10.2337/db05-1187 · Cited by 118
Zheng, C., Yang, Q., Xu, C., Shou, P., Cao, J., Jiang, M., Chen, Q., Cao, G., Han, Y., Li, F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500396113 · Cited by 122
Eringa, E. C., Bakker, W., Smulders, Y. M., Serné, E. H., Yudkin, J. S., & Stehouwer, C. D. A. (2007) · Microcirculation · doi:10.1080/10739680701303584 · Cited by 125
AMPK and the Endocrine Control of Metabolism
Townsend, L. K., & Steinberg, G. R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad012 · Cited by 119
Exercise normalises overexpression of TNF-α in knockout mice
Keller, C., Keller, P., Giralt, M., Hidalgo, J., & Pedersen, B. K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.129 · Cited by 132
n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease
Browning, L. M. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2003252 · Cited by 113
“The TNF-α-knockout mouse model showed improved insulin sensitivity relative to wildtype mice when both were placed on a high-fat diet to induce obesity (Uysal et al. 1997).”
BackgroundResultSerino, M., Menghini, R., Fiorentino, L., Amoruso, R., Mauriello, A., Lauro, D., Sbraccia, P., Hribal, M. L., Lauro, R., & Federici, M. (2007) · Diabetes · doi:10.2337/db07-0360 · Cited by 113
Ryan, K. K., Woods, S. C., & Seeley, R. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.013 · Cited by 113
“…tissue itself produces a wide range of proinflammatory cytokines and acute-phase reactants, including IL-1b, IL-6, and TNFa, contributing to increased systemic inflammation associated with increased adiposity in obese individuals (Hotamisligil, 2005; Rajala and Scherer, 2003; Uysal et al., 1997).”
Mitochondrial sirtuins: Emerging roles in metabolic regulations, energy homeostasis and diseases
Parihar, P., Solanki, I., Mansuri, M. L., & Parihar, M. S. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.12.004 · Cited by 117
“…inactivity, high calorie diet, increased inflammation, reduced fatty acid oxidation, increased oxidative stress, and aging (Petersen et al., 2004; Uysal et al., 1997; Ji and Friedman, 2007) and any effort to regulate these events might be helpful in preventing metabolic disorders (Huang et al.,…”
BackgroundBabió, N., Ibarrola-Jurado, N., Bulló, M., Martínez‐González, M. Á., Wärnberǵ, J., Lete, I. S., Ortega‐Calvo, M., Estruch, R., Serra‐Majem, L., Covas, M. I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058354 · Cited by 126
“Adipocytes, especially in obese subjects, secrete a number of proinflammatory cytokines, [32] some of which have been shown to directly inhibit insulin signalling [33].”
BackgroundDerosa, G., Maffioli, P., SALVADEO, S. A. T., Ferrari, I., Ragonesi, P. D., Querci, F., Franzetti, I., Gadaleta, G., Ciccarelli, L., Piccinni, M. N., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.10.007 · Cited by 120
Vallerie, S. N., Furuhashi, M., Fucho, R., & Hotamisligil, G. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003151 · Cited by 111
“Serum glucose, insulin, and triglyceride levels were measured as described [2,23].”
BackgroundMethodMacronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver
Duwaerts, C. C., & Maher, J. J. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.02.001 · Cited by 125
Okdahl, T., Wegeberg, A., Pociot, F., Brock, B., Størling, J., & Brock, C. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062188 · Cited by 124
Examination of ‘lipotoxicity’ in skeletal muscle of high‐fat fed and ob / ob mice
Turpin, S. M., Ryall, J. G., Southgate, R., Darby, I., Hevener, A. L., Febbraio, M. A., Kemp, B. E., Lynch, G. S., & Watt, M. J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.166033 · Cited by 111
“The cause of the acute caspase 3 activation is unknown but could involve several factors known to be elevated with lipid oversupply including TNFR activation (Uysal et al. 1997), NFκB activation (Sinha et al. 2004) and Fas ligand activation (Lee et al. 2007).”
The role of ADAM17 in metabolic inflammation
Menghini, R., Fiorentino, L., Casagrande, V., Lauro, R., & Federici, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.024 · Cited by 114
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 123
Egr‐1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice
Yu, X., Shen, N., Zhang, M., Pan, F., Wang, C., Jia, W., Liu, C., Gao, Q., Gao, X., Xue, B., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.277 · Cited by 117
“The TNF-a-deficient obese mice have lower levels of circulating free fatty acids and are protected from the obesity-related reduction in the insulin receptor signalling of fat tissues (Uysal et al, 1997).”
Backgroundγδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice
Mehta, P., Nuotio-Antar, A. M., & Smith, C. W. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0414-211rr · Cited by 106
“TNF-a has been shown to play an important role in the AT dysfunction and insulin resistance associated with obesity [31–33].”
BackgroundKim, B., Farruggia, C., Ku, C. S., Pham, T. X., Yang, Y. J., Bae, M., Wegner, C., Farrell, N., Harness, E., Park, Y., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.01.006 · Cited by 122
“TNF [23] and MCP-1 [24], or the ablation of CD11c + cells normalized insulin sensitivity in”
BackgroundTong, Q., Sankalé, J.-L., Hadigan, C. M., Tan, G., Rosenberg, E. S., Kanki, P. J., Grinspoon, S. K., & Hotamisligil, G. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021600 · Cited by 114
Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis
Luna‐Luna, M., Medina-Urrutia, A. X., Vargas‐Alarcón, G., Coss-Rovirosa, F., Vargas‐Barrón, J., & Pérez-Méndez, O. A. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.007 · Cited by 123
Importance of TNF-alpha and its alterations in the development of cancers
Sharif, P. M., Jabbari, P., Razi, S., Keshavarz‐Fathi, M., & Rezaei, N. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155066 · Cited by 120
Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis
Grant, R. W., & Stephens, J. M. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00053.2015 · Cited by 105
Simeoni, E., Hoffmann, M. M., Winkelmann, B. R., Ruiz, J., Fleury, S., Boehm, B. O., M�rz, W., & Vassalli, G. (2004) · Diabetologia · doi:10.1007/s00125-004-1494-4 · Cited by 124
“Adipose tissue functions as an endocrine organ that secretes a number of biologically active proteins, including TNF-α [8], IL-6 [6, 12], IL-8 [13], C-reactive protein, inducible nitric oxide synthase [6], TGF-β1, plasminogen-activator inhibitor-1 (PAI-1) [14], adiponectin [15], resistin [16], leptin [13, 17], macroph…”
BackgroundInfluentialInsulin resistance in patients with rheumatoid arthritis: effect of anti‐TNFα therapy
Rosenvinge, A., Krogh‐Madsen, R., Baslund, B., & Pedersen, B. K. (2007) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740601179605 · Cited by 112
Henstridge, D. C., Whitham, M., & Febbraio, M. A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.08.003 · Cited by 111
“Moreover, in loss-of-function experiments in obese mice, null mutations in the gene encoding TNFa and its receptors resulted in improved insulin sensitivity [16].”
BackgroundHe, J., Usui, I., Ishizuka, K., Kanatani, Y., Hiratani, K., Iwata, M., Bukhari, A., Haruta, T., Sasaoka, T., & Kobayashi, M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0107 · Cited by 108
Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
Møller, H. J., Frikke-Schmidt, R., Moestrup, S. K., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.154724 · Cited by 109
Katagiri, S., Nitta, H., Nagasawa, T., Uchimura, I., Izumiyama, H., Inagaki, K., Kikuchi, T., Noguchi, T., Kanazawa, M., Matsuo, A., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.016 · Cited by 111
Gao, J., Liu, Z. J., Chen, T., & Zhao, D. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2013.879188 · Cited by 111
“In obese subjects, the infiltrated macrophages secrete pro-inflammatory cytokines, such as TNF-a and IL-6 (Hotamisligil et al., 1993; Uysal et al., 1997).”
BackgroundAlternatively Activated Macrophages in Types 1 and 2 Diabetes
Espinoza-Jiménez, A., Peón, A. N., & Terrazas, L. I. (2012) · Mediators of Inflammation · doi:10.1155/2012/815953 · Cited by 101
Adipose tissue macrophages and their polarization in health and obesity
Catrysse, L., & Loo, G. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.03.001 · Cited by 116
Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in Obesity
Costa, R. M., Neves, K. B., Tostes, R. C., & Lobato, N. S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00253 · Cited by 107
“…macrophages-derived TNF-α induces insulin resistance in adipocytes (Pekala et al., 1983); adipose tissue from obese individuals displays increased expression of inflammatory mediators (Hotamisligil et al., 1993; Uysal et al., 1997); and inflammation promotes disturbances in glucose metabolism.”
BackgroundAnti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice
Verty, A. N. A., Stefanidis, A., McAinch, A. J., Hryciw, D. H., & Oldfield, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140592 · Cited by 117
Adipose tissue, inflammation and cardiovascular disease
Ikeoka, D., Mader, J. K., & Pieber, T. R. (2010) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302010000100026 · Cited by 135
The pathophysiology of MASLD: an immunometabolic perspective
Schwärzler, J., Grabherr, F., Grander, C., Adolph, T. E., & Tilg, H. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2294046 · Cited by 117
Nakanishi, N., Yoshida, H., Matsuo, Y., Suzuki, K. S., & Tatara, K. (2002) · Diabetologia · doi:10.1007/s125-002-8243-1 · Cited by 118
Iwata, M., Haruta, T., Usui, I., Takata, Y., Takano, A., Uno, T., Kawahara, J., Ueno, E., Sasaoka, T., Ishibashi, O., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1083 · Cited by 110
Cytokines and inflammation in adipogenesis: an updated review
Jiang, N., Yao, L., Shu, T., & Wang, J. (2019) · Frontiers of Medicine · doi:10.1007/s11684-018-0625-0 · Cited by 114
Wascher, T. C., Lindeman, J. H. N., Sourij, H., Kooistra, T., Pacini, G., & Roden, M. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00221 · Cited by 105
Hypertension in Metabolic Syndrome: Vascular Pathophysiology
Mendizábal, Y., Llorens, S., & Nava, E. (2013) · International Journal of Hypertension · doi:10.1155/2013/230868 · Cited by 100
Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance
Day, C. P., Grove, J., Daly, A. K., Stewart, M., Avery, P. J., & Walker, M. (1998) · Diabetologia · doi:10.1007/s001250050926 · Cited by 117
“More recently it was reported that obese mice homozygous for a targeted null mutation in the TNFa gene were significantly less insulin resistant than normal obese mice [3].”
Antiinflammatory Actions of Klotho: Implications for Therapy of Diabetic Nephropathy
Typiak, M., & Piwkowska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020956 · Cited by 107
The metabolic syndrome: The crossroads between rheumatoid arthritis and cardiovascular risk
Gremese, E., & Ferraccioli, G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.018 · Cited by 118
“Studies in mice suggest that the attenuation of TNF activity improves glucose homeostasis [48].”
BackgroundMolecular Mechanisms of Antipsychotic Drug-Induced Diabetes
Chen, J., Huang, X.-F., Shao, R., Chen, C., & Deng, C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00643 · Cited by 98
“Knockout of TNF-alpha decreased obesity-caused insulin resistance (Uysal et al., 1997).”
BackgroundNerstedt, A., Johansson, A., Andersson, C. X., Cansby, E., Smith, U., & Mahlapuu, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1856-z · Cited by 106
Updating the effects of fatty acids on skeletal muscle
Silveira, L. R., Fiamoncini, J., Hirabara, S. M., Procópio, J., Cambiaghi, T. D., Pinheiro, C. H. J., Lopes, L. R., & Curi, R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21514 · Cited by 104
“TNFa administration reduces insulin sensitivity in mice, an effect that was blocked by inhibition of TNFa and/or TNFa receptor expression (Uysal et al., 1997).”
BackgroundMarrero, M. B., Lucas, R., Salet, C., Hauser, T. A., Mazurov, A., Lippiello, P. M., & Bencherif, M. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154633 · Cited by 97
“…plasma concentrations of inflammatory mediators such as TNF- are increased in the insulin-resistant diabetic state, and that the reduction of the levels of TNF- in diabetic mice correlates with increased insulin sensitivity and decreased plasma insulin and blood glucose levels (Uysal et al., 1997).”
Wei, Y., Whaley-Connell, A. T., Chen, K., Habibi, J., Uptergrove, G. M.-E., Clark, S. E., Stump, C. S., Ferrario, C. M., & Sowers, J. R. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089284 · Cited by 105
Chavakis, T., Chmelar, J., & Chung, K.-J. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-09-0703 · Cited by 101
Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes
Lou, T., Zhang, Z., Xi, Z., Liu, K., Li, L., Liu, B., & Huang, F. (2010) · Inflammation · doi:10.1007/s10753-010-9276-2 · Cited by 112
Mast cells and metabolic syndrome
Zhang, J., & Shi, G.-P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.012 · Cited by 104
Protein glycation during aging and in cardiovascular disease
Simm, A. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.05.012 · Cited by 111
Talbot, N. A., Wheeler-Jones, C. P., & Cleasby, M. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.010 · Cited by 104
“…et al., 2008), while TNFa is generally wellestablished as a mediator of IR, as infusion leads to reduced whole body insulin-mediated glucose uptake in humans (Plomgaard et al., 2005), while knockout of TNFa or its receptors protect mice from obesity (Hotamisligil et al., 1994; Uysal et al., 1997).”
BackgroundHoo, R. L. C., Wong, J. Y. L., Qiao, C., Xu, A., Xu, H., & Lam, K. S. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-67 · Cited by 110
“In obese subjects, infiltrated macrophages together with enlarged adipocytes secrete numerous pro-inflammatory mediators such as IL-6 and TNF-a, which contribute to insulin resistance [6,20].”
BackgroundType 2 diabetes – An autoinflammatory disease driven by metabolic stress
Gonzalez, L. L., Garrie, K., & Turner, M. D. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.034 · Cited by 110
Obesity-related kidney disease: Beyond hypertension and insulin-resistance
Arabi, T. Z., Shafqat, A., Sabbah, B. N., Ashraf, N., Shah, H., Abdulkader, H. S., Razak, A., Sabbah, A. N., & Arabi, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1095211 · Cited by 117
“These proin fl ammatory cytokines are critical to the onset of insulin resistance; mice lacking TNF-a have lower circulating free fatty-acids and are protected from insulin resistance (27).”
Serum Levels of Resistin and Adiponectin in Women with Periodontitis: the Hisayama Study
Saito, T., Yamaguchi, N., Shimazaki, Y., Hayashida, H., Yonemoto, K., Doi, Y., Kiyohara, Y., Iida, M., & Yamashita, Y. (2008) · Journal of Dental Research · doi:10.1177/154405910808700416 · Cited by 112
“type 2 diabetes (Uysal et al., 1997; Kopelman, 2000), and periodontitis is the sixth most common complication of diabetes (Löe, 1993).”
BackgroundConditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance
Röhl, M., Pasparakis, M., Baudler, S., Baumgartl, J., Gautam, D., Huth, M., De Lorenzi, R., Krone, W., Rajewsky, K., & Brüning, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18712 · Cited by 103
“While both in vitro and in vivo experiments have revealed that TNF-α–induced insulin resistance is mediated predominantly through the p55 TNF receptor, the intracellular signaling cascade that leads to this effect remains unclear (9).”
BackgroundAdipocyte Ceramides—The Nexus of Inflammation and Metabolic Disease
Chaurasia, B., Talbot, C. L., & Summers, S. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576347 · Cited by 106
Galic, S., Sachithanandan, N., Kay, T. W., & Steinberg, G. R. (2014) · Biochemical Journal · doi:10.1042/bj20140143 · Cited by 99
Defining the genetic contribution of type 2 diabetes mellitus
van Tilburg, J. H. O., van Haeften, T. W., Pearson, P. L., & Wijmenga, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.569 · Cited by 126
Tharaheswari, M., Reddy, N. J., Kumar, R., Varshney, K. C., Kannan, M., & Sadras, S. R. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2152-x · Cited by 114
He, J., Chen, L.-X., & Li, H. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.02.033 · Cited by 108
A Focused Review of the Metabolic Side-Effects of Clozapine
Yuen, J. W. Y., Kim, D. D., Procyshyn, R. M., Panenka, W. J., Honer, W. G., & Barr, A. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.609240 · Cited by 106
Yoshida, H., Takamura, N., Shuto, T., Ogata, K., Tokunaga, J., Kawai, K., & Kai, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.060 · Cited by 108
“Additionally, several reports suggest that TNF-a indirectly promotes insulin resistance by increasing the circulating levels of free fatty acid (FFA) [8–10].”
BackgroundMoldes, M., Lasnier, F., Gauthereau, X., Klein, C., Pairault, J., Fève, B., & Chambaut-Guérin, A.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105726200 · Cited by 100
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, E., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 97
Wallace, C. W., & Fordahl, S. C. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000196 · Cited by 107
da Costa, R. M., Neves, K. B., Mestriner, F., Louzada‐Júnior, P., Bruder-Nascimento, T. B., & Tostes, R. C. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0443-0 · Cited by 107
“Uysal (1997) demonstrated that TNF-α deficient mice are protected against HFD-induced increased glucose and insulin levels, but not body weight gain [37].”
BackgroundWinkler, G., Lakatos, P., Salamon, F., Nagy, Z., Speer, G., Kovács, M., Harmos, G., Dworak, O., & Cseh, K. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00052.x · Cited by 101
An update on immune dysregulation in obesity‐related insulin resistance
Daryabor, G., Kabelitz, D., & Kalantar, K. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12747 · Cited by 96
Yang, W., Jiang, W., & Guo, S. (2023) · Nutrients · doi:10.3390/nu15214671 · Cited by 115
“Fructose-stimulated endotoxin release increases TNF production in liver macrophages, mediating fructose-induced hepatic insulin resistance and lipogenesis [97,98].”
BackgroundThe implication of proinflammatory cytokines in type 2 diabetes
Guest, C. (2008) · Frontiers in Bioscience · doi:10.2741/3074 · Cited by 98
PAI-1 Produced Ex Vivo by Human Adipose Tissue Is Relevant to PAI-1 Blood Level
Morange, P. E., Alessi, M. C., Verdier, M., Casanova, D., Magalon, G., & Juhan-Vague, I. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1361 · Cited by 100
Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
Sidiropoulos, P. I., Karvounaris, S. A., & Boumpas, D. T. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2397 · Cited by 100
Metadata
- Authors
- Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S.
- Affiliations
- Harvard University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Hotamisligil, Gkhan S.
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 610-614
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1764140709
- Cited by
- 2,234
- References
- 26
- Citations by year
- 2026: 15 · 2025: 39 · 2024: 40 · 2023: 48 · 2022: 50 · 2021: 77 · 2020: 79 · 2019: 79 · 2018: 80 · 2017: 96 · 2016: 71 · 2015: 111 · 2014: 106 · 2013: 141 · 2012: 122
- FWCI
- 33.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- TNF-α, insulin resistance, obesity, diet-induced obesity, ob/ob mice, free fatty acids, insulin receptor signaling, type 2 diabetes, adipose tissue, skeletal muscle
- MeSH terms
- Adipose Tissue, Animals, Fatty Acids, Glucose, Glucose Tolerance Test, Homeostasis, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Monosaccharide Transport Proteins, Muscle Proteins, Mutation, Obesity, Phosphorylation, Receptor, Insulin, Triglycerides, Tumor Necrosis Factor-alpha, Signal Transduction, Receptors, Tumor Necrosis Factor, Glucose Transporter Type 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.